Member Info for 2reincarnated

Both will be sub 0.5p atsome point next year!

No administration this year as it is funded. It has a proven product so just needs a partner.

And that is not going to happen. Those that could make happen are set to lose out the most.

Flat finish/slight rise on cards?

Along with Oxford Biodynamics, Beluscara, Immupharma and Verici DX. Buy at 0.25p or better still, not at all!

Just like Oxford Biodynamics was!

What else could it be?

Immupharma could do the same soon. But from where to where?

This could go sub 1p soon, before hitting 10p!

Thanks Golfdinger.

Correct me if I 'm wrong, but it means shareholders will be given the chance to buy at a higher price than the current at a specified time?

Will the SP be higher at this time?

Do we have any idea as to what the new share issue price is likely to be?

The harder it rises today, the harder it will fall tomorrow!

Worth a punt when it falls to 0.25p!

Perhaps tomorrow?

WAYNESMITH, we don't know exactly what is a sell and buy yet! The SP could recover flat.

Both rose early this year, both based on pants!

Trellus is down to where it was before the hype, expect Immupharma to drop sub 1p again. However, no reason why both cannot hit +10 this year!

By the way Rookie1, pull yourself together please. What people say on this BB does not impact any bit on the SP or buying/selling dynamics!

The rights issue question relates to debt and not sales and growth. If a RI is announced when sales improve because growth has returned to the UK, it will not cause the SP to drop like suggested. If growth improves so much, CD & R may take advantage of the SP weakness to buy the company on the cheap.

So we are very likely to have the placing at 0.5p

The last placing was done at 1p, so expect 0.5p to be hit next!

If earnings are as expected, we should see SP recovery and the worst may well be behind us.

The SP seems to "shoot first then ask questions."